Click here to see a list of our past events.
Celebrating International Women’s Day with Trailblazing Women in Life Sciences
Join JLABS for Breaking Ground: Women Who Lead, a dynamic panel discussion honoring International Women’s Day. This inspiring event shines a spotlight on the remarkable contributions of female scientists, researchers and entrepreneurs who are transforming the life sciences landscape.
Beyond their professional achievements, our distinguished panelists will share personal stories of resilience, determination and innovation. They’ll delve into the challenges they’ve faced as women in the industry, the barriers they’ve overcome, and the pivotal moments that shaped their journeys.
This event offers:
- Inspiring Perspectives: Gain insights from women who are driving breakthroughs in life sciences, from groundbreaking research to entrepreneurial ventures.
- Authentic Stories: Hear firsthand accounts of navigating gender biases, pursuing leadership and thriving in traditionally male-dominated fields.
- Meaningful Connections: Engage with a community of life sciences professionals and advocates dedicated to fostering inclusivity and innovation.
Whether you’re a scientist, entrepreneur or advocate, this discussion promises to leave you motivated and empowered to break new ground in your own career. Together, let’s celebrate the strength, creativity and resilience of women who lead.
Join us at the Future of Care Conference 2025: Innovation for the Next Generation, New York City's premier student-driven, accessible healthtech conference, sponsored by Weill Cornell Medicine.
We are taking an interdisciplinary approach to our conference highlighting the three themes of Digital Health & Medical Technologies, Biotechnology & Clinical Innovation, and Healthcare Systems & Sustainability.
We have a stellar lineup of thought leaders, innovators and passionate individuals who will share groundbreaking ideas and transformative technologies in health care today.
Speakers include:
Innocent Clement, M.D., MPH, M.B.A., Founder & CEO of Ciba Health
Elizabeth Wood, Ph.D., CEO of Jura Bio
This is a great opportunity to connect with future leaders, explore groundbreaking ideas and build a healthier tomorrow.
RSVP at futureofcare.nyc.
Applications are open for the Summer 2025 Prototyping Hardware Accelerator at Rev: Ithaca Startup Works!
Over 10 weeks, Rev’s in-person Prototyping Hardware Accelerator guides product teams to determine if their ideas are commercially desirable, technologically feasible, and economically viable. Upon completion of the program, participants are positioned to recruit team members, bring on partners, initiate work with contract manufacturers, and pitch to investors. Teams will receive a stipend of up to $2,000 to advance their prototype.
Want to learn more? Register to attend an upcoming virtual information session. Questions? Contact rev@revithaca.com.
Cornell Research & Innovation offers the virtual Innovation & Entrepreneurship Workshop Series to faculty, staff, post-docs, graduate and undergraduate students, and alumni at Cornell University to explore the potential of launching a business grounded in research. Questions? Contact crea@cornell.edu.
Ready to secure non-dilutive funding to take your startup to the next level?
Join Kirk Macolini, President of InteliSpark, LLC, for this virtual workshop providing insights into the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) application process. During the workshop, Macolini will discuss and answer questions regarding writing and submitting a successful SBIR/STTR proposal and identifying strategies for making your SBIR/STTR proposal more competitive.
Upon registering, participants will receive access to the SBIR/STTR video series, a set of short videos containing valuable background information, which they are encouraged to view prior to the workshop. The pre-workshop video series covers:
- An overview of the SBIR/STTR programs
- Program eligibility requirements
- Differences between SBIR and STTR agencies
- Using SBIR/STTR to enhance your company's value
Register here. Questions? Contact sbirassistance@cornell.edu.
BioVenture eLab is excited to invite you to our upcoming special replay of the 2024 Accelerating BioVenture Innovation Final Pitch Competition, originally held on December 5, 2024.
In anticipation of an invitation-only alumni dinner on February 27, 2025, featuring first-prize winner Tornado Therapeutics, we’re hosting a watch party to build excitement and celebrate the ABI participants' hard work.
If you didn't have a chance to join us at the live event, come watch the Zoom replay as five finalists, comprised of Tri-I researchers and clinicians, compete for the best business plan in front of VC and industry judges. You won't want to miss this venerable Tri-I ecosystem celebration!
RSVP here.
Are you a STEM researcher interested in making an impact with your technology innovation? The National Science Foundation’s I-Corps program can provide you with professional training, mentoring, and up to $50,000 in funding for customer discovery.
Hosted by the Interior Northeast I-Corps Hub (IN I-Corps), this virtual NSF I-Corps Information Session is designed for busy graduate students, postdocs, and faculty interested in learning more about I-Corps regional and national programming. NSF I-Corps instructor John Inserra and I-Corps alum Thomas Conroy, founder of SensVita, will be in attendance to share their experience and answer questions.
The NSF created I-Corps (Innovation Corps) to bridge the gap between fundamental research discoveries in science and engineering and the commercialization of technologies, products, and processes with the potential to benefit society.
Register here.
Interested in understanding the journey from biomarker discovery to real-world healthcare applications? Researchers and innovators are invited to this insightful discussion on navigating the path from discovery to commercial success in the biomarker and diagnostics space.
Industry leaders and successful entrepreneurs will share practical insights on identifying commercially viable biomarkers, early-stage validation, test development, regulatory pathways, and integration into clinical practice. Whether you're considering commercialization or actively developing diagnostic solutions, this panel offers valuable perspectives on turning promising research into market-ready products.
Moderated by Iris Bica, a Business Development and Licensing Associate for the Center of Technology Licensing at Weill Cornell Medicine, the panel will feature:
- Dan Klass, Senior Director of Emerging Technologies, Freenome
- Marieke Spaan, Senior Director Corporate Development, SkylineDx
- Daniel Lunz, CEO & Co-Founder, Previse
Register now.
As an early-stage startup founder, you’ll need help and guidance to advance your company. Accelerators and incubators can provide key resources like mentorship, funding, workspace and connections with potential partners and investors. In this free workshop, you’ll learn how to choose and apply for the right program to support your startup’s growth and success.
Moderated by Deanna Kocher, Associate Director of Hardware Programs at Rev: Ithaca Startup Works, the panel discussion will feature:
- Pooja Patel, founder of Equipad and alum of Rev’s three Hardware Accelerators
- Monica Gertz, CEO of MyophonX and Runway Startup Postdoc at Cornell Tech
- Greg Ray, Cornell Entrepreneur in Residence
This exciting program is designed to efficiently advance early stage projects, that have the potential to benefit patients, to proof of concept studies. Sanders TDI contributes medicinal chemistry and drug development capabilities that complement the deep scientific expertise already available in our research community.
The recipients of Sanders TDI support will be selected by a Request for Proposal (RFP) process. To select the most promising projects in the most unbiased manner possible, Sanders TDI draws upon a scientific advisory board (SAB) comprised of recognized scientific and thought leaders drawn from the biopharmaceutical industry, the venture capital community, and the faculty of WCMC, RU and MSKCC (for a list of members please see the About Sanders TDI web page: https://www.tritdi.org/leadership/). The SAB utilizes well-established, stringent criteria to select the most competitive and transformational projects for execution. The SAB also helps to oversee and assess progress of the selected projects, which are milestone-driven and designed to reach specified value-inflection points.
The project application is a three-step process:
- Submission of a letter of intent (LOI) that includes a basic description of the project, describes the unmet medical need, and provides a scientific rationale the project. The Letter of Intent is due Thursday, Feb 13, 2025.
- A full application package (8-10 pages) that will be requested from PIs whose LOIs describe projects that fit well with the Sanders TDI mission.
- Review of the application by the Sanders TDI Small Molecule Scientific Advisory Board.
